Dr Zoe Cournia, Assistant Professor at the Biomedical Research Foundation, Academy of Athens (BRFAA) in Greece, was the recipient of the first PRACE Ada Lovelace Award in 2016. She and her team’s research focused on computer-aided drug design techniques for targeting the mutated cancerous PI3Kα protein with small molecule inhibitors, and for the inhibition of the c-Myc-Max interaction and the Arp2/3 protein complex using small molecules. The results of this research were featured in the PRACE Digest 2015. The interview with Zoe Cournia recorded at PRACEdays16 can be viewed below.
“Using the PRACE HPC resources and recent advances in computer-aided drug design allow us to develop drugs specifically designed for a given protein, shortening the time for development of new drugs. I believe that our work is a good example of how computers help develop candidate drugs that have the potential to save millions of lives worldwide. I am honoured to receive this prestigious award and hope that this serves as inspiration to other female researchers in the field.”